Medios AG

Update in progress

ILM1.DE (XETRA)

Medios AG and its subsidiaries supply specialty pharmaceutical drugs, mainly in Germany, through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. Patient-Specific Therapies makes medicines for pharmacies, including cytostatic and antibody therapies and parenteral nutrition. International Business handles global API procurement, sterile and non‑sterile drugs, and distribution to public and hospital pharmacies and homecare. Pharmaceutical Supply covers oncology, neurology, autoimmunity, ophthalmology, infectious diseases, and hemophilia. Founded 2015, Berlin.